PT95093A - Metodos para a culturizacao de hvc em celulas eucarioticas - Google Patents

Metodos para a culturizacao de hvc em celulas eucarioticas

Info

Publication number
PT95093A
PT95093A PT95093A PT9509390A PT95093A PT 95093 A PT95093 A PT 95093A PT 95093 A PT95093 A PT 95093A PT 9509390 A PT9509390 A PT 9509390A PT 95093 A PT95093 A PT 95093A
Authority
PT
Portugal
Prior art keywords
culturization
hvc
methods
cells
eucariotic
Prior art date
Application number
PT95093A
Other languages
English (en)
Other versions
PT95093B (pt
Inventor
Amy J Weiner
Kathelyn S Steimer
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23576300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT95093(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT95093A publication Critical patent/PT95093A/pt
Publication of PT95093B publication Critical patent/PT95093B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Details Of Audible-Bandwidth Transducers (AREA)
  • Telephone Function (AREA)
  • Measurement Of Mechanical Vibrations Or Ultrasonic Waves (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT95093A 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas PT95093B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39866789A 1989-08-25 1989-08-25

Publications (2)

Publication Number Publication Date
PT95093A true PT95093A (pt) 1991-05-22
PT95093B PT95093B (pt) 1997-11-28

Family

ID=23576300

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95093A PT95093B (pt) 1989-08-25 1990-08-24 Metodos para a culturizacao de hvc em celulas eucarioticas

Country Status (12)

Country Link
EP (1) EP0414475B1 (pt)
JP (3) JPH05502156A (pt)
AT (1) ATE161041T1 (pt)
AU (1) AU655156B2 (pt)
CA (1) CA2064705C (pt)
DE (1) DE69031791T2 (pt)
DK (1) DK0414475T3 (pt)
ES (1) ES2110411T3 (pt)
GR (1) GR3026114T3 (pt)
IE (1) IE903097A1 (pt)
PT (1) PT95093B (pt)
WO (1) WO1991002820A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
GR1001261B (el) 1989-12-18 1993-06-30 Wellcome Found Ιϊκός παράγων.
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
AU7679491A (en) * 1990-04-04 1991-10-30 Protos, Inc. Hepatitis c virus protease inhibitors
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2065690A1 (en) * 1991-04-10 1992-10-11 Hiroaki Okamoto Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0610436B9 (en) 1991-11-21 2003-03-26 Common Services Agency Hepatitis-c virus testing
US5552310A (en) * 1992-06-12 1996-09-03 Hiroshi Yoshikura Replication of hepatitis C virus genome and identification of virus having high infectivity
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5851758A (en) * 1995-10-25 1998-12-22 Childrens Research Institute Cytopathic replication of hepatitis C virus in a new cell line
US6242187B1 (en) 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
EP0852626B1 (en) * 1996-01-29 2002-04-03 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
CA2269097C (en) 1996-11-08 2007-01-09 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Synthesis and purification of hepatitis c virus-like particles
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
AT407256B (de) * 1998-06-24 2001-02-26 Immuno Ag Hepatitis c-virus positive endometriale zelllinie
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
CA2618429A1 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
EP0071640B1 (en) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
EP0261233A4 (en) * 1986-04-01 1988-08-29 Genelabs Inc IMMORTALIZED TISSUE CELLS WITH VIRAL SPECIFICITY.
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン

Also Published As

Publication number Publication date
JP2004049235A (ja) 2004-02-19
EP0414475A1 (en) 1991-02-27
ATE161041T1 (de) 1997-12-15
DE69031791D1 (de) 1998-01-22
AU655156B2 (en) 1994-12-08
IE903097A1 (en) 1991-02-27
DE69031791T2 (de) 1998-04-02
JP2001314192A (ja) 2001-11-13
AU6344990A (en) 1991-04-03
DK0414475T3 (da) 1998-02-09
CA2064705A1 (en) 1991-02-26
WO1991002820A1 (en) 1991-03-07
GR3026114T3 (en) 1998-05-29
CA2064705C (en) 1999-04-06
ES2110411T3 (es) 1998-02-16
JPH05502156A (ja) 1993-04-22
EP0414475B1 (en) 1997-12-10
PT95093B (pt) 1997-11-28

Similar Documents

Publication Publication Date Title
PT95093A (pt) Metodos para a culturizacao de hvc em celulas eucarioticas
DK219087A (da) Vektorsystem til brug ved transformation af trichoderma, transformerede trichodermastammer og fremgangsmaade til fremstilling af proteiner heri
PT86640A (pt) Hepatitis b virus surface antigens and hybrid antigens containing them
AU3614384A (en) Anti-idiotype antibodies & their use in inducing immulogical response to viruses & tumours
FI870104A7 (fi) Negatiivisia, valosähköisen vastuksen omaavia koostumuksia ja menetelmiä lämmönkestävien negatiivikuvien valmistamiseksi käyttämällä niitä.
HU9502949D0 (en) Polipeptides, polinucleotides, vectors and host cells, and vaccines against hepatitis virus infection, diagnostics, immunoassay and culturing methods
DE58909029D1 (de) Bauelement zur Absorption von Energie.
ATE161040T1 (de) Kultivierung von vero-zellen
BR8400588A (pt) Forno de fusao por inducao em alta frequencia e processo de preparacao de materiais ceramicos,por fusao,por inducao em alta frequencia
DE69534595D1 (de) Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
MY101236A (en) Grid ceiling
DE3476221D1 (en) Method for obtaining human hepatocytes cultures, cultures obtained thereby and biological and biochemical applications thereof
BR7701233A (pt) Processo e aparelho de conduzir correntes de ar
ATE114713T1 (de) Biomasse zur produktion von virus/virusantigen.
ATE8409T1 (de) Verfahren zum vermehren menschlicher hepatitis-a viren in einer zellkultur in vitro.
DE69021496D1 (de) Integrierter Prozess zur Produktion von Diisopropylether und Benzin.
EP0019218A3 (en) Influenza virus vaccines, process for preparing them, process for propagating influenza viruses and cell culture inoculated with influenza virus
ES2177531T3 (es) Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.
DE69016693D1 (de) Züchtung von transformierten Mikroorganismen.
DK713188D0 (da) Fremgangsmaade til fremstilling af pregneno-oxazoliner
DK628188A (da) Protein og fremgangsmaade til fremstilling deraf
DE59410140D1 (de) Rinderovarzellinie (FROv) zur Virusvermehrung
DK0433845T3 (da) Fremgangsmåde til fremstilling af 2-acylamino-9-acyl-6-halogen-puriner
JPS5250989A (en) Method of preparing alfin catalyst
FR2585722B1 (fr) Co-cultures d'hepatocytes et de cellules epitheliales de foie traitees

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19901214

FG3A Patent granted, date of granting

Effective date: 19970826

PD4A Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120827